Recyte Therapeutics Inc., a subsidiary of Biotime Inc., both of Alameda, Calif., said a paper reporting the isolation of pericyte-like cells from human embryonic stem cells was published online in Scientific Reports. Recyte researchers said the pericyte-like cells represent a type of cell that is specialized to support and strengthen blood vessels. The pericytes may serve as a source of cells to promote new blood flow in patients suffering from ischemic vascular disease, according to the company.